Marja Puurunen, PhD

Global Clinical Lead, Hemophilia
Sanofi

Poster(s):

• (223) Fitusiran Prophylaxis Reduces Episodic Treatment-Associated Costs of Managing Breakthrough Bleeds in Hemophilia
  Wednesday, October 29, 2025